BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○
Discoveries/DIMETHYLPHENYLPIPERAZINIUM IODIDE
✓ X-VAULT VERIFIEDEXPLORATORYNOVELTY: LOW

DIMETHYLPHENYLPIPERAZINIUM IODIDE

HIV Infection candidate

313.5
discovery score
PubMed Studies
33
Novelty
Low
Signal
Exploratory
Sealed
May 20, 2026
BiohacksAI Hypothesis

Dimethylphenylpiperazinium iodide may modulate the HIV Infection pathway based on its molecular target profile in the BiohacksAI corpus. This compound shows biological activity against validated targets with limited prior literature coverage, suggesting an understudied mechanism-of-action with potential research value.

Computational hypothesis based on target graph analysis. Not a confirmed mechanism. Independent experimental validation required.

Mechanism Discovery Graph
HIV InfectionHost Interactions o…DiseaseVif-mediated degrad…APOBEC3G mediated r…Infectious diseaseCHAINEUCHRO…CHRNA7CHRNA10APOBEC…TLR3CHRNA4RGS12DIMETHYLP
High-value target (Tier 3)
Research target (Tier 2)
Standard target
Pathway
Biological Plausibility

The HIV Infection pathway is a validated biological target area with established relevance in human disease and health research.

Dimethylphenylpiperazinium iodide shows target overlap with compounds previously characterized in this pathway within the BiohacksAI corpus of 31,590 graph entities and 1.51M PubMed studies.

Low literature coverage (33 studies) relative to target engagement indicates this mechanism may be undercharacterized in current scientific literature — a signal consistent with early-stage discovery candidates.

Novelty Indicators
Literature coverage
33 PubMed studies
Low coverage = higher novelty potential
Discovery score
313.46
target_count × pathway_diversity / log(studies + 2)
Mechanism area
HIV Infection
Primary biological pathway
Novelty rating
Low
Derived from score + literature coverage
Research Context
◈
Literature coverage
33 PubMed studies indexed at time of discovery
◈
X-Vault timestamp
Sealed May 20, 2026 — cryptographic proof of discovery date and corpus version
◈
Corpus scope
BiohacksAI corpus only — not a comprehensive literature or patent database search
◈
Mechanism area
HIV Infection — computationally derived, requires experimental confirmation

This section reflects computational signal strength only. All findings require independent expert validation before any research or commercial use.

Suggested Validation Steps
1HIV Infection pathway target binding assay
2Dose-response curve (EC50 determination)
3Cellular viability and selectivity panel
4In vitro ADMET profiling

Validation roadmap is algorithmically derived from pathway context. Full experimental protocol available in Priority Signal discovery reports.

Target Relevance
CHAIN
Standard
EUCHROMATIC
Standard
CHRNA7
Standard
CHRNA10
Standard
APOBEC3G
Standard
TLR3
Standard

Target tier based on BiohacksAI HIGH_VALUE_TARGETS registry.

Discovery Lineage
Generated byBiohacksAI Discovery Engine
Engine versionDISCOVERY_v1.0
Corpus versioncurrent
Graph entities31,590 compounds analyzed
PubMed coverage1.51M studies
Discovery dateMay 20, 2026 at 02:00 AM UTC
X-Vault Evidence SealXVAULT_v1
Discovery IDDISC-dimethylphenylpiperazini-20260520-83fe750f
Event Hash—
Chain Hash—
Vault Index#—
Sealed At2026-05-20T02:00:02.559Z
Verify this discovery →↓ Demo PDF (X-Vault sealed)

Demo report — computational hypothesis only. Not validated. For X-Vault verification testing.

Full Discovery ReportLOCKED
🔒
Mechanism hypothesis (expanded)
Detailed molecular mechanism with target confidence scores and binding context
🔒
Complete target mapping
All validated molecular targets with affinity data and evidence levels
🔒
Biological pathway network
Full pathway coverage map with crosstalk and downstream effects
🔒
Graph position + related compounds
Structural neighbors in the BiohacksAI compound graph — potential analogs
🔒
Supporting PMIDs
Curated PubMed references with relevance ranking
🔒
X-Vault sealed PDF
Cryptographically verified 20-30 page discovery report

Interested in this discovery? Contact us for access and licensing details.

Contact us about this discovery →

All discoveries are computational hypothesis candidates — not confirmed mechanisms. Independent experimental validation is required before any research or commercial use. Organiq Sweden AB · BiohacksAI β